P. Créquit

发表

Future of evidence ecosystem series: 1. Introduction - Evidence synthesis ecosystem needs dramatic change.

I. Boutron, P. Ravaud, J. Craig, 2020, Journal of clinical epidemiology.

Mapping of Crowdsourcing in Health: Systematic Review

Philippe Ravaud, Mehdi Benchoufi, Perrine Créquit, 2018, Journal of medical Internet research.

Published trials of TACE for HCC are often not registered and subject to outcome reporting bias

I. Boutron, M. Ronot, V. Vilgrain, 2020, JHEP reports : innovation in hepatology.

Published trials assessing TACE for the treatment of HCC are often non registered and subject to bias

I. Boutron, M. Ronot, V. Vilgrain, 2020 .

Brain Metastasis in Patients with Non-Small Cell Lung Cancer: Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

M. Wislez, V. Gounant, J. Cadranel, 2015 .

Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000–2015

J. Jacot, R. Porcher, P. Ravaud, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second‐line treatment for non–small‐cell lung cancer wild‐type or unknown status for EGFR

L. Trinquart, P. Ravaud, J. Cadranel, 2018 .

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis

L. Trinquart, P. Ravaud, A. Chaimani, 2017, BMC Medicine.

Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov

R. Porcher, P. Ravaud, S. Mourah, 2015, Genetics in Medicine.

Clinical Benefit, Price and Approval Characteristics of FDA-approved New Drugs for Treating Advanced Solid Cancer, 2000-2015.

J. Jacot, R. Porcher, P. Ravaud, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of Late-Life Expectancy for Assessing the Long-Term Benefit of Immune Checkpoint Inhibitors.

R. Porcher, P. Créquit, A. Vivot, 2019, Journal of the National Cancer Institute.

EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.

M. Antoine, M. Wislez, C. Chouaid, 2016, Lung cancer.

Availability of results of academic randomized trials involving cooperative groups in oncology in France: a systematic search of clinical trial registries.

B. Milleron, P. Créquit, A. Vivot, 2022, Journal of cancer policy.

Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates

C. Hamard, M. Antoine, M. Wislez, 2017, AIDS.

Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France

G. Hejblum, C. Chouaid, P. Créquit, 2016, PloS one.

Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor

Philippe Ravaud, Ludovic Trinquart, Perrine Créquit, 2016, BMJ Open.

Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystem.

I. Boutron, P. Ravaud, J. Craig, 2020, Journal of clinical epidemiology.

Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer

Philippe Ravaud, Ludovic Trinquart, Perrine Créquit, 2016, BMC Medicine.

[Lung cancer in HIV-infected patients].

M. Antoine, M. Wislez, J. Cadranel, 2018, Bulletin du cancer.

Avoidable waste of research related to outcome planning and reporting in clinical trials

I. Boutron, P. Ravaud, A. Dechartres, 2018, BMC Medicine.

[Lung cancer in HIV-infected patients].

M. Antoine, M. Wislez, J. Cadranel, 2017, Bulletin du cancer.

2014 update on non-small cell lung cancer (excluding diagnosis).

B. Milleron, M. Antoine, M. Wislez, 2014, Diagnostic and interventional imaging.

Effect of cannabis and tobacco on emphysema in patients with spontaneous pneumothorax.

V. Gounant, J. Cadranel, P. Créquit, 2018, Diagnostic and interventional imaging.

Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov.

R. Porcher, P. Ravaud, A. Dechartres, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

' s response to reviews Title : Comparative efficacy and safety of second-line treatments for v-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor : a systematic review and network meta-analyses

L. Trinquart, P. Ravaud, A. Chaimani, 2017 .

Future of evidence ecosystem series: 2. Current opportunities and need for better tools and methods.

Isabelle Boutron, Philippe Ravaud, Hywel Williams, 2020, Journal of clinical epidemiology.

Living network meta-analysis was feasible when considering the pace of evidence generation.

Philippe Ravaud, Ludovic Trinquart, Perrine Créquit, 2019, Journal of clinical epidemiology.

Results of trials assessing transarterial chemoembolization for treating hepatocellular carcinoma are critically underreported

I. Boutron, M. Ronot, V. Vilgrain, 2020, European Radiology.

Accuracy in detecting inadequate research reporting by early career peer reviewers using an online CONSORT-based peer-review tool (COBPeer) versus the usual peer-review process: a cross-sectional diagnostic study

J. Regnaux, D. Moher, I. Boutron, 2019, BMC Medicine.

Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analyses.

Philippe Ravaud, Ivan Lerner, Ignacio Atal, 2019, Journal of clinical epidemiology.

Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review

M. Antoine, M. Wislez, V. Gounant, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review

I. Boutron, P. Créquit, A. Paludan-Müller, 2021, BMC Medicine.

Improving on Tail-of-the-Curve Evaluation With the American Society of Clinical Oncology Value Framework.

R. Porcher, P. Créquit, A. Vivot, 2018, JAMA oncology.

[Chemotherapy at the end of life for patients with lung cancer. A practice analysis].

C. Chouaid, P. Créquit, M. Didier, 2015, Revue des maladies respiratoires.